Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
June 03, 2025
Risk vs. benefit: Bisphosphonates in breast cancer
These common drugs can curb metastasis to bone and may even keep DCIS in check, but side effects make education and awareness crucial
Exercise is medicine
Move your body for better health, especially before, during and after cancer treatment. Do whatever you can; it all helps (just don’t injure yourself!)
Hutchinson Center receives $4.6 million to study biomarkers of common diseases among postmenopausal women
Phase two of Women's Health Initiative supports three new Center research projects
Initial Results of the Study of Tamoxifen and Raloxifene (STAR) Released: Osteoporosis Drug Raloxifene Shown to be as Effective as Tamoxifen in Preventing Invasive Breast Cancer
Hutchinson Center Participated in Clinical Trial